European Commission President Ursula von der Leyen announced that the EU has achieved its goal of completing vaccination of 70% of the adult population with the new crown vaccine.
According to reports, the EU set a target to complete vaccination of 70% of the population over the age of 18 with the new crown vaccine by the end of summer, or 256 million people. Ursula von der Leyen said this goal has been reached, but “we must go further.” She added that more Europeans need to continue to be vaccinated, in addition to the need to work together to support vaccination in other parts of the world.
According to data from the European Centre for Disease Prevention and Control, while more than 70 percent of the EU’s adult population has been vaccinated against the new crown, there are significant differences between member states. Only about 20 percent of the adult population in Bulgaria has completed vaccination, compared to 32.8 percent in Romania, 49 percent in Slovakia, 58.1 percent in Poland, 70.6 percent in Germany, 72.5 percent in France, 76.7 percent in Spain, 82.4 percent in Portugal and 85.5 percent in Ireland. EU Health Commissioner Stella Kyriakides said that it is necessary to reduce the vaccination gap between the different member states and that it is important to exceed the level of 70% vaccination coverage for the new crown under the influence of the variant new crown virus, and that it is necessary to continue to continuously strengthen vaccination in order to get rid of the epidemic.
Delta variant neo-coronavirus is already dominant in Europe and is 40% to 60% more infectious than alpha variant neo-coronavirus, according to research published in the United Kingdom. The World Health Organization has expressed concern that vaccination in Europe has “stalled” and expects 236,000 new cases of Neoplasia in Europe between now and Dec. 1.
On July 27, the European Commission announced that it had met its goal of providing at least one dose of the new coronary vaccine to 70 percent of adults. Among the four new crown vaccines approved for use by the European Medicines Agency, a single dose of the Johnson & Johnson vaccine is a completed vaccination, but the Pfizer, Modena, and AstraZeneca vaccines require two doses to be a completed vaccination, and only one dose is required for those who have recovered from new crown infection.
French Health Minister Olivier Veyran said on Aug. 31 that as of Aug. 29, nearly 10 million people over the age of 12 in France are eligible for the New Crown vaccine but have not received even one dose, and the health department is paying special attention to 600,000 of them who are over the age of 80 and strongly recommends that they go for vaccination. In addition, about 2 million people in the 12 to 17 age group, 2.5 million in the 18 to 34 age group and 2.2 million in the 35 to 49 age group in France have not yet been vaccinated.